Related Experiment Video
Updated: Jul 15, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Environmental scan of current strategies to decrease sedative-hypnotic drug use and promote sleep in hospital
Heather L Neville1, Jenna Shaw2,3, Carter VanIderstine2,3
1Nova Scotia Health Authority, 1276 South Park Street, Halifax, Nova Scotia, B3H 2Y9, Canada. Heather.neville@nshealth.ca.
Many resources exist to help patients and providers reduce sedative-hypnotic drug use and improve sleep. While hospital-specific resources are limited, identified tools can guide non-pharmacologic sleep promotion strategies.
Area of Science:
- Geriatric Medicine
- Pharmacology
- Sleep Medicine
Background:
- Sedative-hypnotic drugs are frequently prescribed in hospitals for insomnia and anxiety.
- Guidelines recommend against their use, especially in older adults, due to significant risks like falls, fractures, and delirium.
- There is a need for evidence-based, non-pharmacologic alternatives to manage sleep issues in hospital settings.
Purpose of the Study:
- To identify publicly accessible resources aimed at reducing sedative-hypnotic drug utilization.
- To find strategies that promote better sleep in hospital patients.
- To assess the availability and nature of non-pharmacologic interventions for sleep in healthcare settings.
Main Methods:
- An extensive Google search utilizing six distinct search strategies was performed.
- Key organizational websites were also systematically searched for relevant resources.
- Inclusion criteria focused on publicly available, English-language resources from the past five years, employing non-pharmacologic methods for sleep promotion or sedative reduction.
Main Results:
- A total of 79 resources met the inclusion criteria.
- The majority focused on patient education (82.3%) and sleep hygiene strategies (39.2%).
- Other interventions included deprescribing (21.5%), relaxation training (16.5%), cognitive behavioral therapy for insomnia (11.4%), and policy development (8.9%).
Conclusions:
- Numerous resources are available to support patients and healthcare providers in decreasing sedative-hypnotic drug use and enhancing sleep quality.
- Resources specifically tailored for hospital environments were less common, though some recommended discontinuing hospital-initiated sedatives upon discharge.
- Healthcare organizations can adapt these identified resources to create effective sedative-hypnotic prescribing programs and policies.
Related Concept Videos
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

